ABSTRACT. We prospectively investigated urinary iodine concentration (UIC) in pregnant women and in female, non-pregnant controls in the canton of Berne, Switzerland, in 1992. Mean UIC of pregnant women [205±151 μg iodine/g creatinine (μg I/g Cr); no.=153] steadily decreased from the first (236±180 μg I/g Cr; no.=31) to the third trimester (183±111 μg I/g Cr, p<0.0001; no.=66) and differed significantly from that of the control group (91±37 μg I/g Cr, p<0.0001; no.=119). UIC increased 2.6-fold from levels indicating mild iodine deficiency in controls to the first trimester, demonstrating that high UIC during early gestation does not necessarily reflect a sufficient iodine supply to the overall population. Pregnancy is accompanied by important alterations in the regulation of thyroid function and iodine metabolism. Increased renal iodine clearance during pregnancy may explain increased UIC during early gestation, whereas increased thyroidal iodine clearance as well as the iodine shift from the maternal circulation to the growing fetal-placental unit, which both tend to lower the circulating serum levels of inorganic iodide, probably are the causes of the continuous decrease of UIC over the course of pregnancy. Mean UIC in our control group, as well as in one parallel and several consecutive investigations in the same region in the 1990s, was found to be below the actually recommended threshold, indicating a new tendency towards mild to moderate iodine deficiency. As salt is the main source of dietary iodine in Switzerland, its iodine concentration was therefore increased nationwide in 1998 for the fourth time, following increases in 1922, 1965 and 1980. (J. Endocrinol. Invest. 26: 389-396, 2003) INTRODUCTION Dietary iodine supply, usually assessed by measuring urinary iodine concentration (UIC), has received considerable attention worldwide (1, 2) . About one fifth of Earth's population is at risk of iodine deficiency (ID), 200-300 million people present with disturbed thyroid function or a goiter caused by ID, about 20 million suffer from ID-induced mental retardation and about 6 million are cretins (3) . Goiter is endemic in most European countries, and a rec-ommended minimal iodine supply of 150 μg/day for adults and of 175-200 μg/day for pregnant women (4) [or a urinary concentration of 150 μg iodine/g creatinine (μg I/g Cr) and 175-200 μg I/g Cr, respectively, assuming a mean 24 h urinary creatinine excretion of 1.0 g in women (5) ] is achieved only in a few regions (6, 7) . Thyroid disorders caused by ID range from discrete functional disturbances to mild intellectual impairment to full-blown cretinism (8, 9) . In pregnant women, a tendency towards an increase of TSH within physiological limits was observed even under conditions of only mild to moderate ID (with UIC of 50-100 μg iodine/day [μg I/d]) (10, 11) . Continuous monitoring of a group at risk of developing latent hypothyroidism under conditions of marginal iodine supply, such as pregnant women, is essential (10, 11) .
The goal of the present study was to evaluate random individual and sequential UIC data of pregnant women in the Bernese region in Switzerland in 1992, in order to compare them with data in the literature. Determining UIC levels of pregnant women in Switzerland seemed an important topic of research, especially since UIC levels which had been shown to be adequate in Switzerland in the 1980s appeared to be moderately insufficient in the 1990s in the same region (12) (13) (14) . This insufficiency probably reflects a decrease in dietary iodine supply, and is assumed to be due to changes in nutritional habits (12, 13) .
MATERIAL AND METHODS Subjects
From the end of February to early April 1992 we investigated UIC and urinary creatinine concentration (UCC) in spot urine samples of 192 pregnant women from six different regions in the canton of Berne, Switzerland (Interlaken, Heimberg, Burgdorf, Biel, Thun and Berne) and of 124 healthy, non-pregnant women from the regions of Berne (no.=71) and Burgdorf (no.=53) who served as controls. After written informed consent was obtained, gynecologists and general practitioners collected spot urine samples of consecutive pregnant (at any stage of pregnancy) and non-pregnant women, respectively, on the occasion of routine consultations at various times of the day. The samples were collected in conventional 10 ml plastic tubes and frozen immediately (no.= 50, 66, and 76 samples from the first, second and third trimesters, respectively). Significant circadian (15) and seasonal (16) rhythms of UIC, with higher UIC values in late afternoon compared to early morning and during winter compared to summer, were not reported in the medical literature until after the sampling period, and thus were not taken into consideration in the study design. All women completed a questionnaire on preexisting thyroid diseases, consumption of iodized vs non-iodized salt at home, special diets, intake of medicines (in particular multiple vitamins or oligoelements) and exposure to contrast media or other iodine-containing pharmaceuticals. In order to confirm the low initial UIC values of part of the Berne control group and to exclude a transiently insufficient supply, 36 non-pregnant control women with values <100 μg I/l were reevaluated (= Berne repetition) in November 1992. The results of the group of pregnant women from the region of Burgdorf were confusing. The mean UIC values of this group (859±504 μg I/g Cr; or 583±345 μg I/l; no.=27, p<0.001) significantly exceeded those of all other groups. 85% of the values exceeded 300 μg I/g Cr, and 44% even exceeded 1000 μg I/g Cr. There were no differences regarding the socio-demographic characteristics, results from the questionnaires and UCC compared with the groups from other regions. Perineal or vaginal disinfecting with an iodine-containing solution at the gynecologist's was ruled out. When an evaluation of healthy, non-pregnant women in Burgdorf one year later (91±42 μg I/g Cr; or 95±73 μg I/l; no.=50) revealed a mean UIC in line with the values of the non-pregnant women from the region of Berne, we assumed a transient and short-term iodine contamination of unknown origin and excluded the whole Burgdorf group of pregnant women from the calculations. After exclusion of extreme UIC values (see statistics), a total of 153 spot urine samples from pregnant women (no.=31, 56 and 66 in the first, second and third trimesters, respectively) and of 119 samples from non-pregnant women remained. In order to compare our UIC findings with data from the literature, we calculated the mean UIC (and not medians, as used in other epidemiological studies) of the groups. Though the controls were not matched for age, the pregnant women (29.7±4.4 yr) and the controls (27.8±5.6 yr) did not differ significantly. In accordance with previously published studies (10, (17) (18) (19) (20) , pregnancy was divided arbitrarily into weeks 1-16, 17-29, and 30 to delivery, corresponding to the first, second and third trimesters, respectively. Of the 50 pregnant women who had been included during the first trimester, 34 and 31 women collected a further urine sample during the second and third trimesters, respectively. In 15 women, UIC could be studied sequentially (one urine sample from each trimester).
Analytical methods
All laboratory analyses were performed at the Division of Clinical Chemistry, Inselspital, University of Berne, Switzerland. Total iodine was determined using the wet ash method based on the Sandell-Kolthoff reaction (21) and with the same Technicon Autoanalyzer (Technicon, Tarrytown, NY) used in previous studies in this region since 1975 (13, 22, 23) . Creatinine was determined with a Hitachi 911 Autoanalyzer (Boehringer, Mannheim, Germany) using the picric acid method of Jaffé. A detailed description of the analytical methods has been given previously (14, 24) . The method used in the present study for iodine measurement gives results closely comparable to a modified Sandell-Kolthoff procedure (24) , which again correlates very well with a method using inductively coupled plasma mass spectrometry (25) . The iodine/creatinine ratio in urine samples was shown to provide a reliable estimation of iodine intake (26) and has been used in literature on urinary iodine measurements. Since the renal clearances of iodine and creatinine are altered to the same extent in pregnancy, the iodine/creatinine ratio represents a valid parameter for longitudinal studies of urinary iodine concentration during gestation (27, 28) .
Statistics
The results were analyzed statistically using t test. Extreme values were identified by the formula T=(x-d)/ Standard deviation (SD), in which x = presumptive extreme value, d = mean value of the group without x, and SD without x. Provided there is a normal distribution, T will have a maximum value of 3.402 within groups of 30 members, for a level of significance of 99%.
RESULTS

UIC in pregnant women
As summarized in Table 1 , the mean ±SD UIC of all pregnant women (205±151 μg I/g Cr; or 204±202 μg I/l; no.=153) differed significantly from the control group (91±37 μg I/g Cr or 91±68 μg I/l; p<0.0001; no.=119). Except for the group from the region of Thun, every single group of pregnant women differed significantly from the control group. Age, preexisting thyroid diseases and diets did not influence UIC. None of the study participants declared an intake of pre-natal foodstuffs or of pharmaceuticals with known relevant iodine contents. The mean UIC increased 2.6-fold during the first trimester compared with the control group and thereafter steadily decreased from the first (236±180 μg I/g Cr; or 267±317 μg I/l; no.=31) to the second (213±170 μg I/g Cr; or 206±175 μg I/l; no.=56) and the third (183±111 μg I/g Cr; or 172±138 μg I/l; p<0.0001; no.=66) trimester. The median (range) values (extreme values not excluded) were 85 (24-575) μg I/g Cr (no.=124) for the controls and 183 (46-5335) μg I/g Cr (no.=36), 153 (69-729) μg I/g Cr (no.=59) and 143 (58-2205) μg I/g Cr (no.=67) for the first, second and third trimester, respectively.
This pattern was confirmed in the spot urine samples from the 15 sequentially studied women, with a significant decrease of mean UIC from the first (258±192 μg I/g Cr; or 325±353 μg I/l) to the third trimester (153±70 μg I/g Cr; or 183±121 μg I/l; p<0.0001), while UCC remained unchanged ( Table 2) .
Distribution of the UIC data
Although the mean UIC of all pregnant women exceeded the recommended lower threshold of 175 -200 μg I/g Cr (4), 96 values (63%) were found below this limit and 28 values (18%) were found in the range of 50-100 μg I/g Cr. Thirty one (20%) and twenty-nine (19%) of the pregnant women compared to zero and three (3%) of the non-pregnant women had UIC data above 300 μg I/g Cr and 300 μg I/l urine, respectively. Five, three and one of the excluded extreme UIC values from pregnant women were from the first, second and third trimester, respectively (see statistics and Table 1 ). (1) Numbers of samples after exclusion of extreme values (see statistics and Table 1 ). Significance vs controls: (2) none, (3) p<0.0001. Significance vs 1 st trimester: (4) p<0.0001. Trimesters 1, 2 and 3 denote weeks 1-16, 17-29 and 30 to delivery, respectively. UIC = urinary iodine concentration, UCC = urinary creatinine concentration, μg I/l urine = μg iodine/l urine, μg I/g Cr = μg iodine/g creatinine. To convert UCC from mmol/l to g/l divide by 8.840.
DISCUSSION
In the Bernese region, where mild ID prevailed, UIC in 153 pregnant women was found to be significantly higher than in a control group of non-pregnant women. Compared to the controls, the UIC during the first trimester of pregnancy increased 2.6-fold and decreased progressively over the second to the third trimester. However, even in the third trimester, UIC values were still significantly higher in pregnant women than in non-pregnant controls.
UIC throughout pregnancy
As summarized in Fig. 1 , the available data from the literature suggest an increased mean UIC during gestation, unless the mean UIC in the reference populations is below approximately 75 μg I/g Cr (or <75 μg I/l urine). Under conditions of severe ID in a region of former Eastern Germany (mean UIC 21±14 μg I/g Cr in non-pregnant women aged 18-35 yr), mean UIC values in mid-and late gestation were found to be lower than those of the respective controls (columns A and C in Fig. 1 ) (17, 18) . This was also true after improvement of iodine supply to about 50-75 μg/day [mean UIC in the control group estimated from Fig. 2 in reference (18) at about 70 μg I/g Cr, indicating moderate ID]. In a small group from another severely iodine-deficient region in Italy (not shown in Fig. 1 ), UIC during pregnancy was found to be clearly below that of the control population (29±16 μg I/g Cr; no.=16 vs 49±43 μg I/g Cr; level of significance not reported) (29) . One study performed in Denmark (not shown in Fig. 1 ) and one study from Belgium (columns B in Fig. 1 ), both with a mean UIC of about 50-75 μg I/day (or 50-75 μg I/l urine) in the respective reference populations, revealed an unchanged UIC during pregnancy (10, 30, 31) . In two Irish populations with a UIC of 80±1.6 μg I/l and 94±6.8 μg I/g Cr in the non-pregnant controls, UIC throughout pregnancy was significantly increased in comparison with the respective controls (columns D and E in Fig. 1) (19, 20) . In a region of Iran with a comparably high UIC of about 200 μg I/l in the controls, UIC during pregnancy did not differ significantly from non-pregnant women (not shown in Fig. 1 ) (32) .
UIC in early gestation (1 st trimester)
The mean UIC in the present study was found to be highly significantly increased during the first trimester (236±180 μg I/g Cr) compared with the control group (91±37 μg I/g Cr; columns F in Fig.  1 
columns B
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Fig. 1 -In studies with a mean UIC in the controls above approximately 75 μg I/l urine or μg I/g Cr (columns D, E, F), mean UIC during pregnancy is increased. In studies with a mean UIC in the controls below approximately 75 μg I/l urine or μg I/g Cr (columns A, B, C), mean UIC during pregnancy remains stable or even decreases. Mean urinary iodine concentration of the control group Bauch 1993 was estimated from
. Data comparison between the different authors and regions is limited, since values are reported in different units. μg I/g Cr = μg iodine/g creatinine. μg I/l urine = μg iodine/l urine. no. = number of spot urine samples. Columns and the values above the columns refer to mean UIC data; vertical lines indicate standard deviations (+ 1 SD). Significance
vs respective controls: *p<0.05; **p<0.01; ***p<0.0001.
URINARY IODINE CONCENTRATION DURING GESTATION Comparison of own data with the literature [according to Banch 1993 (18), extended]
where in two different studies a mean UIC of 148±6 μg I/g Cr (control group 80±1.6 μg I/g Cr, p<0.001; columns D in Fig. 1 ) and 176±18 μg I/g Cr (control group 94±7 μg I/g Cr, p<0.01; columns E in Fig. 1) were found in the first trimester (19, 20) . Under conditions of mild to severe ID, UIC in the first trimester was reported to increase slightly (no level of significance reported) in another study (columns A in Fig. 1) (17) . The exact UIC values of the control populations of two other studies (columns B and C in Fig. 1 ) from regions with mild ID are not available (UIC in the control group about 50-75 μg I/g Cr) (10, 18) .
Decrease of UIC in the 2 nd and 3 rd trimesters
In our sequentially studied urine samples of 15 women, the mean UIC decreased significantly from the first to the third trimesters, while the mean UCC remained unchanged ( Table 2 ). As summarized in Fig. 1 , UIC decreased in the course of pregnancy in the present and in most of the previously published investigations (10, 18, 19, 20) . In a large group of pregnant women from Belgium (not shown in Fig. 1 ), a similar decreasing shift from 58±2 μg I/l in early gestation to 49±2 μg I/l in late gestation was reported (33) . The increase of UIC in early gestation as well as the decrease during the course of pregnancy probably reflects two major physiological changes. First, with pregnancy, renal clearance of iodide increases significantly due to an increased glomerular filtration rate (27, 28) . This iodide loss tends to lower the circulating levels of inorganic iodide and induces, in turn, a compensatory increase in the thyroidal iodide clearance (11, 27, 34) . The rapid postpartum return of UIC to pre-pregnant values documented in the literature is probably due to normalization of renal clearance as well as placental loss, and suggests a direct effect of pregnancy on urinary iodine output (11, 17, 19, 20) . In areas with moderate ID, serum inorganic iodide levels decrease already during early gestation (11, 27) . This may explain why in such regions mean UIC throughout pregnancy does not increase or even decreases as compared to that of non-pregnant women (10, 17, 18, 29, 30) . Second, later on during gestation, a part of the available iodide pool is shifted from the maternal circulation to the expanding fetal-placental unit (11, 35) , leading to an additional, progressive decrease of circulating levels of inorganic iodide. The increased thyroidal iodide clearance and the shift to the fetal-placental unit may explain the observations of progressive UIC decrease during gestation. To our knowledge, there are no available data con-cerning the existence and location of an active regulation system of renal retention or secretion of halogens and especially of iodide.
High individual UIC values during pregnancy
In the present study, the mean UIC of all pregnant women exceeded the recommended lower threshold of 175-200 μg I/g Cr (4). One-fifth of the pregnant women compared to zero of the non-pregnant women had UIC values above 300 μg I/g Cr. Nevertheless, two-thirds of the UIC values from pregnant women did not reach the 175 μg I/g Cr threshold and one-fifth was even found to be in the low range of 50-100 μg I/g Cr. The existence of high intra-individual variability (13) , as well as the significant relevance of a circadian rhythm of UIC (15) , was unknown in 1992 when the urinary samples for the present study were collected. We cannot exclude that urine spots in the controls might have been sampled more often during morning hours, whereas pregnant women might have sampled throughout the day. As UIC has been found to be lower in the morning than in the afternoon, this potential methodological bias may represent an additional explanation for the higher frequency of high and sometimes very high UIC data in pregnant women compared with the controls. In another Swiss study performed after salt iodide concentration had been increased in 1998, i.e., under different baseline conditions than in the present study, roughly one-fifth of 511 pregnant women [estimated from Fig. 2 in reference (36)] had a UIC above 300 μg I/l throughout pregnancy. In this study 13% of all pregnant women declared consumption of an iodine-containing supplement (36) compared to none in the present investigation. Higher mean UIC values in early compared to late gestation are unlikely to result from a methodological bias, as the UIC pattern throughout pregnancy found in the random individual (expressed as mean and median values) as well as in the sequential samples were closely comparable. Since UIC decreases in the course of pregnancy, and because mid-(no.=56/153) and late-(no.=66/153) gestational periods were somewhat over-represented in our sample series, the average UIC over the whole pregnancy as well as the average UIC during the first trimester could likely have shifted to even higher values in a numerically more balanced study population.
Pregnancy and iodine metabolism
Pregnancy constitutes a challenge for both the maternal and fetal thyroid glands and induces ma-jor alterations of iodine metabolism (11, 37) . Two excellent and comprehensive surveys concerning regulation of thyroid function during pregnancy have been published (11, 35) . The increased frequency of goiter during or after pregnancy has repeatedly been confirmed (10, 11, 20, 30, 38) . The pathogenesis of goiter has also been discussed in detail recently (39) (40) (41) . Thyroid disorders are observed four-to five-fold more frequently in women than in men (11) . Whether thyroid stimulation during gestation is causal and sufficient to explain later development of autonomous thyroid growth and function in women is still unknown.
Iodine supplementation during pregnancy
In regions with mild to severe ID, supplementation by iodine or by iodine plus L-thyroxine during pregnancy prevented an increase of the thyroid volume in the mothers and the newborns and attenuated or suppressed an increase of maternal TSH levels in several published studies (17, 30, 31) . One single study, however, reported an increase of thyroid volumes in pregnant women despite supplementation by 300 μg I/d and no effect on the maternal TSH levels (42) . It might be possible that these contradictory results are due to a lack of compliance in some of the subjects (as UIC data in a quarter of the treated pregnant women remained very low) or to the higher supplementation dose in comparison with other studies. The available literature does not definitely answer questions on the optimal dose, timing, or duration of iodine supplementation with relation to pregnancy. Whether it is beneficial to give iodine supplements to pregnant women under conditions of only borderline ID remains unknown and requires further evaluation. Nevertheless, since a tendency towards an increase of TSH levels arises even under conditions of only mild to moderate ID (with UIC of 50-100 μg I/d) in pregnant women (10, 11) , iodine supplementation (with 150-200 μg I/d) during pregnancy should seriously be considered, at least until a sufficient level of UIC has been documented in women of child-bearing age within the population. It cannot be stressed enough that even if children have UIC levels indicating sufficient iodine supply, women of child-bearing age in the same population may present UIC indicating significant ID (43) .
Low UIC in the control group
After table salt in Switzerland had been supplemented with increasing concentrations of potassium iodide in 1922, 1965 and 1980 (with 5, 10 and 20 mg/kg, respectively), urinary iodine concentration rose from less than 30 μg I/24 h in 1920 to a UIC of more than 150 μg I/g Cr in the 1980s, indicating sufficient supply (23) . However, average UIC in our control group of 119 nonpregnant women (91±37 μg I/g Cr) was in good agreement with data from a parallel investigation of adults (87±40 μg I/g Cr; no.=54) (12) , with two later studies in the same region (15) and in different parts of Switzerland (44, 45) , indicating a new tendency towards mild to moderate ID, especially in young female adults (43) . Because in the present study UIC values of some non-pregnant women from Berne (Berne repetition) were confirmed unchanged by a second measurement seven months after the initial collection, a transiently insufficient iodine supply could be ruled out. Only 6% of our individual values reached the recommended threshold of 150 μg I/g Cr (4), and as much as 8% of the values were found to be below 50 μg I/g Cr. Two potential biases may be ruled out. The UCC of our controls did not differ from previous investigations in the same region (46) , and a seasonal variation of UIC related to the intake of milk and fresh milk products was shown to be significant only in children, who have a high milk intake, but not in adult women, who consume much less milk (16) . As a consequence, given that in Switzerland salt is still the main source of dietary iodine, supplementation was increased nationwide in 1998 for the fourth time.
CONCLUSIONS
In conclusion, UIC during early pregnancy increases under conditions of mild to moderate ID and decreases from early to late gestation. These variations are caused by physiological adaptations of thyroid and renal clearances of iodide. Therefore, as UIC during pregnancy does not necessarily reflect the actual iodine supply, interpretation of UIC during pregnancy has to be performed with caution. The question of which UIC threshold in pregnant women reliably reflects sufficient iodine supply requires further evaluation.
